...
首页> 外文期刊>Critical reviews in oncology/hematology >Neuroendocrine Merkel cell nodal carcinoma of unknown primary site: Management and outcomes of a rare entity
【24h】

Neuroendocrine Merkel cell nodal carcinoma of unknown primary site: Management and outcomes of a rare entity

机译:原发部位未知的神经内分泌默克尔细胞淋巴结癌:罕见实体的管理和结局

获取原文
获取原文并翻译 | 示例
           

摘要

Merkel cell nodal carcinoma of unknown primary (MCCUP) is a rare neuroendocrine tumour with distinct clinical and biological behaviour. We conducted a review of retrospective data extracted from 90 patients focusing on the management and outcome of this disease. We also compared life expectancy of these patients with the outcome of patients with known Merkel primaries and with neuroendocrine cancers of unidentifiable primary. There is a limited body of data for this type of malignancy, however, patients with Merkel cell nodal carcinoma of unknown primary site, seem to have better survival when treated aggressively than patients with cutaneous Merkel tumours of the same stage and equal survival with patients with low-grade neuroendocrine tumour of unknown origin. The lack of prospective trials, and the inadequate data, hamper the management of these tumours. Establishment of treatment guidelines is urgently needed. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
机译:未知原发性默克尔细胞淋巴结癌(MCCUP)是一种罕见的神经内分泌肿瘤,具有独特的临床和生物学行为。我们对90例患者的回顾性数据进行了回顾,重点研究了该病的治疗和预后。我们还比较了这些患者的预期寿命与已知默克尔原发灶和原发性神经内分泌癌患者的预后。这类恶性肿瘤的数据有限,但是,原发部位未知的默克尔细胞淋巴结癌患者,积极治疗后似乎比同期具有相同阶段皮肤性默克尔肿瘤的患者具有更好的生存率,并且与来源不明的低度神经内分泌肿瘤。缺乏前瞻性试验和数据不足阻碍了这些肿瘤的治疗。迫切需要制定治疗指南。 (C)2014 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号